国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2011年
3期
218-221
,共4页
李坑%龚素波%徐礼%张莉%向旭东
李坑%龔素波%徐禮%張莉%嚮旭東
리갱%공소파%서례%장리%향욱동
三氧化二砷%哮喘%免疫%炎症
三氧化二砷%哮喘%免疫%炎癥
삼양화이신%효천%면역%염증
Arsenic trioxide%Asthma%Immunity%Inflammation
支气管哮喘(简称哮喘)是一种由多种细胞(嗜酸粒细胞、T细胞、中性粒细胞、肥大细胞及肺泡上皮细胞等)及细胞组分参与的气道慢性炎症性疾病.三氧化二砷在动物实验中能改善哮喘小鼠的肺功能,在临床治疗中能使患者的哮喘症状得到长期控制.新近研究表明:三氧化二砷能明显抑制小鼠的体液免疫反应,抑制小鼠的肺、皮肤等组织的T细胞增殖,能下调IL-17、IL-18和IL-23等多种炎症因子的分泌,并且通过内质网应激途径诱导中性粒细胞凋亡,从而调节免疫,抑制炎症.文章综述了三氧化二砷调控哮喘免疫及气道炎症的最新研究进展,并进行了展望.
支氣管哮喘(簡稱哮喘)是一種由多種細胞(嗜痠粒細胞、T細胞、中性粒細胞、肥大細胞及肺泡上皮細胞等)及細胞組分參與的氣道慢性炎癥性疾病.三氧化二砷在動物實驗中能改善哮喘小鼠的肺功能,在臨床治療中能使患者的哮喘癥狀得到長期控製.新近研究錶明:三氧化二砷能明顯抑製小鼠的體液免疫反應,抑製小鼠的肺、皮膚等組織的T細胞增殖,能下調IL-17、IL-18和IL-23等多種炎癥因子的分泌,併且通過內質網應激途徑誘導中性粒細胞凋亡,從而調節免疫,抑製炎癥.文章綜述瞭三氧化二砷調控哮喘免疫及氣道炎癥的最新研究進展,併進行瞭展望.
지기관효천(간칭효천)시일충유다충세포(기산립세포、T세포、중성립세포、비대세포급폐포상피세포등)급세포조분삼여적기도만성염증성질병.삼양화이신재동물실험중능개선효천소서적폐공능,재림상치료중능사환자적효천증상득도장기공제.신근연구표명:삼양화이신능명현억제소서적체액면역반응,억제소서적폐、피부등조직적T세포증식,능하조IL-17、IL-18화IL-23등다충염증인자적분비,병차통과내질망응격도경유도중성립세포조망,종이조절면역,억제염증.문장종술료삼양화이신조공효천면역급기도염증적최신연구진전,병진행료전망.
Bronchial asthma (asthma) is a kind of chronic inflammation of airway, which was involved in many kinds of cells and cellular elements, such as eosinophils, T lymphocytes, neutrophil granulocytes, mastocytes, alveolar epithelial cells, and so on. Arsenic trioxide can improve the asthmatic mice's pulmonary function in experiment, and own the ability of hold the patients' asthmatic symptoms in a better state for a long time. The recent researchs indicated that the arsenic trioxide can regulate immunity and inhibit airway inflammation through many effective processes, such as inhibiting humoral immunity and proliferation of T lymphocytes at skin and lung, down-regulating expression of inflammatory factors (IL-17, IL-18, IL-23,etc), and inducing apoptosis of neutrophil granulocytes by endoplasmic reticulum stress pathway. The newest studies about the regulation on immunity and airway inflammation of asthma by arsenic trioxide were summarized, and some possible research orientation was previewed.